MG
HGEN

Michael Gelband’s HUMANIGEN, INC. HGEN Stock Holding History

Michael Gelband’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,171
Closed -$57K – 2440
2022
Q2 		$57K Sell
32,171
-1,987
-6% -$4.46K ﹤0.01% 1791
2022
Q1 		$103K Sell
34,158
-128,721
-79% -$344K ﹤0.01% 2003
2021
Q4 		$606K Buy
+162,879
New +$953K 0.01% 1300
2021
Q2 		– Sell
-29,964
Closed -$572K – 2958
2021
Q1 		$572K Sell
29,964
-95,649
-76% -$1.75M 0.01% 1252
2020
Q4 		$2.2M Buy
125,613
+93,190
+287% +$1.12M 0.02% 504
2020
Q3 		$345K Buy
+32,423
New +$333K 0.01% 1213

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Michael Gelband's HGEN Position: Q3 2022 in Review

Michael Gelband sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 32,171 shares — an estimated $57K sold.

Michael Gelband first reported a position in HGEN in Q3 2020 and held it in 6 quarters. The position peaked at $2.2M in Q4 2020. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Michael Gelband reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Michael Gelband sold 32,171 HUMANIGEN, INC. shares in Q3 2022, an estimated $57K.
  • Michael Gelband first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 6 quarters.
  • Michael Gelband's HUMANIGEN, INC. position peaked at $2.2M in Q4 2020.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.